Country · Healthcare markets

Japan healthcare markets

178 reports across 5 categories, with market size and growth to 2033.

Fastest-growing in Japan

2023–2033 CAGR · estimates

  1. 1Blockchain in Genomics 38.8% $139 Mn → $3.7 Bn
  2. 2Artificial Intelligence (AI) Machine Learning(ML) in Healthcare 38.5% $118 Mn → $3.1 Bn
  3. 3Artificial Intelligence (AI) in Medicine 38% $516 Mn → $12.9 Bn
  4. 4Digital Biomarkers 36% $274 Mn → $5.9 Bn
  5. 5Artificial Intelligence (AI) in Remote Patient Monitoring 30.9% $56 Mn → $826 Mn
  6. 6Blockchain-as-a-Service 29.8% $131 Mn → $1.8 Bn
  7. 7Artificial Intelligence (AI) in Radiology 29.1% $37 Mn → $480 Mn
  8. 8Connected Healthcare Market 27.6% $3.7 Bn → $41.8 Bn

By category

Biggest markets in Japan

Market size in 2023

  1. 1Hospitals and Health Systems $270.8 Bn
  2. 2Healthcare IT $30 Bn
  3. 3Nutritional Supplements $23.9 Bn
  4. 4Home Healthcare $22.5 Bn
  5. 5Dietary Supplements $19.1 Bn
  6. 6Healthcare Information System $18 Bn
  7. 7Functional Food $17.7 Bn
  8. 8IoT in Healthcare $11.2 Bn

Most clinical trials in Japan

Active trials (recruiting, about to start or running)

  1. 1Point of Care Diagnostics 366
  2. 2Ambulatory Surgery Center 366
  3. 3Dermatology Diagnostic 142
  4. 4Breast Cancer Diagnostic 140
  5. 5Home Healthcare 60
  6. 6Decentralized Clinical Trials(DCTs) 55
  7. 7Brain Imaging, Biomarkers and NeuroInformatics 42
  8. 8Alzheimers Dignostic 42

Health in Japan: WHO figures

Japan: People and health spending

Companies most covered in Japan

Medtronic30 reports Johnson & Johnson27 reports Abbott Laboratories25 reports Pfizer Inc.24 reports GE Healthcare23 reports Siemens Healthineers21 reports Novartis AG19 reports Philips Healthcare16 reports Bayer AG15 reports Merck & Co., Inc.15 reports Sanofi15 reports IBM Watson Health13 reports

All 178 Japan markets

Each market name opens its Japan report. To compare one market across every country, see market statistics.

Digital Health 41 markets
Digital Health markets in Japan
Market20232033 (projected)CAGR Active trials
3D Laparoscopy Imaging Systems $199 Mn $399 Mn 7.2% 0
3D Printed Implants $224 Mn $830 Mn 14% 0
3D Printing in Medical Application $149 Mn $987 Mn 20.8% 2
Artificial Intelligence (AI) in Drugs Discovery $37 Mn $394 Mn 26.6% 3
Artificial Intelligence (AI) in Healthcare – – – 19
Artificial Intelligence (AI) in Life Sciences $137 Mn $1.5 Bn 27.2% 12
Artificial Intelligence (AI) in Medical Imaging $56 Mn $551 Mn 25.7% 6
Artificial Intelligence (AI) in Medicine $516 Mn $12.9 Bn 38% 19
Artificial Intelligence (AI) in Pharma – – – 3
Artificial Intelligence (AI) in Radiology $37 Mn $480 Mn 29.1% 1
Artificial Intelligence (AI) in Remote Patient Monitoring $56 Mn $826 Mn 30.9% 0
Artificial Intelligence (AI) Machine Learning(ML) in Healthcare $118 Mn $3.1 Bn 38.5% 19
Blockchain in Genomics $139 Mn $3.7 Bn 38.8% 0
Blockchain-as-a-Service $131 Mn $1.8 Bn 29.8% 0
Brain Imaging, Biomarkers and NeuroInformatics $42 Mn $70 Mn 5.2% 42
Brain PET-MRI Systems $21 Mn $42 Mn 7% 25
Clinical Alarm Management $108 Mn $157 Mn 3.8% 1
Clinical Data Management Systems $155 Mn $500 Mn 12.4% 2
Connected Healthcare Market $3.7 Bn $41.8 Bn 27.6% 1
Decentralized Clinical Trials(DCTs) $102 Mn $423 Mn 15.3% 55
Dental 3D Printing $211 Mn $1.4 Bn 21% 0
Dental CAD/CAM $206 Mn $560 Mn 10.5% 1
Digital Biomarkers $274 Mn $5.9 Bn 36% 6
Digital diabetes care $798 Mn $4.9 Bn 19.8% 3
Digital Pathology Systems $75 Mn $281 Mn 14.2% 12
Digital Therapeutics $423 Mn $3 Bn 21.5% 40
Digital Twin $106 Mn $969 Mn 24.8% 1
Digital X-ray $1.1 Bn $2 Bn 6.3% 16
Electronic Health Record $2.2 Bn $3.6 Bn 4.7% 9
Healthcare Information System $18 Bn $91.3 Bn 17.6% 181
Healthcare IT $30 Bn $100.9 Bn 12.9% 50
Home Healthcare $22.5 Bn $50.4 Bn 8.4% 60
Internet Of Things In Healthcare $6.2 Bn $31.1 Bn 17.5% 0
IoT in Healthcare $11.2 Bn $56.8 Bn 17.6% 0
Long-term Care Software $218 Mn $745 Mn 13.1% 6
Mental Health Apps $348 Mn $2.4 Bn 21.2% 1
Pathology Imaging Systems $101 Mn $324 Mn 12.4% 12
Point of Care Diagnostics $2.8 Bn $6 Bn 7.9% 366
Remote Medication Management $241 Mn $1.2 Bn 17.5% 1
Remote Patient Monitoring $98 Mn $527 Mn 18.3% 4
Werable Healthcare Devices $2 Bn $12.9 Bn 20.3% 4
Healthcare Services 24 markets
Healthcare Services markets in Japan
Market20232033 (projected)CAGR Active trials
Alopecia areata – – – 12
Alzheimers Dignostic $131 Mn $267 Mn 7.4% 42
Ambulance Service $1.9 Bn $4 Bn 7.6% 61
Ambulatory Surgery Center $2.5 Bn $4.7 Bn 6.6% 366
Antimicrobial Susceptibility Testing – – – 2
Bioinformatics $758 Mn $3 Bn 14.9% –
Biomaterial Wound Dressing $510 Mn $1 Bn 7.2% 1
Blood Gas and Electrolyte Analyzers $174 Mn $339 Mn 6.9% 5
Bone Cancer Diagnostic $68 Mn $146 Mn 7.9% 36
Brain Cancer Diagnostic $93 Mn $349 Mn 14.1% 26
Breast Cancer Diagnostic $255 Mn $566 Mn 8.3% 140
Clinical Laboratory Service – – – –
Dental Care Service – – – –
Dental Imaging $211 Mn $473 Mn 8.4% –
Dermatology Diagnostic $1.6 Bn $4.9 Bn 11.7% 142
Fertility Service $1.3 Bn $2.5 Bn 6.6% –
Healthcare Electronic Data Interchange (EDI) $249 Mn $639 Mn 9.9% 2
Healthcare In Vitro Diagnostic $5.2 Bn $7.9 Bn 4.3% 3
Hospitals and Health Systems $270.8 Bn $489.5 Bn 6.1% 1,855
Medical Billing $280 Mn $861 Mn 11.9% 1
Medical Tourism $4.6 Bn $15.2 Bn 12.7% 0
Nursing Education $640 Mn $1.5 Bn 8.6% 5
Patient Support Programs (PSP) $1.1 Bn $4.8 Bn 16.3% 12
Point Of Care (PoC) Molecular Diagnostic $1.2 Bn $3 Bn 9.8% 31
Medical Devices 27 markets
Medical Devices markets in Japan
Market20232033 (projected)CAGR Active trials
Acute Care Needleless Connectors $31 Mn $66 Mn 8% –
Advanced Bipolar Direct Energy Devices $193 Mn $465 Mn 9.2% –
Aesthetic Lasers and Energy Devices $101 Mn $330 Mn 12.6% –
Air Ambulance Life Support Solutions $278 Mn $695 Mn 9.6% –
Airway Management Devices $124 Mn $216 Mn 5.7% –
Anastomosis Devices $196 Mn $396 Mn 7.3% –
Anesthesia & Respiratory Devices $1.8 Bn $4.6 Bn 10% –
Anesthesia Monitoring Devices $164 Mn $557 Mn 13% –
Angiography Devices $774 Mn $1.5 Bn 6.8% –
Angioplasty Balloons $252 Mn $385 Mn 4.3% –
Anti-Snoring Devices $78 Mn $189 Mn 9.3% –
Apheresis Equipments $158 Mn $302 Mn 6.7% –
Arrhythmia Monitoring Devices $374 Mn $669 Mn 6% –
Assisted Walking Aids $143 Mn $256 Mn 6% –
Audiology Devices $487 Mn $949 Mn 6.9% –
Defibrillator $1.1 Bn $2 Bn 6.4% –
Dental Articulators $24 Mn $47 Mn 6.9% –
Dental Caries Detectors $23 Mn $73 Mn 12.3% –
Dental Diagnostic and Surgical Equipments $745 Mn $1.5 Bn 7.6% –
Dental X-Ray Equipments $109 Mn $228 Mn 7.7% –
Diabetes Care Devices $2.6 Bn $4.9 Bn 6.4% –
Digital Diabetes Management – – – –
Direct Energy Medical Devices $686 Mn $1.2 Bn 5.5% –
Disposable Surgical Devices $562 Mn $1.2 Bn 7.8% –
Insulin Delivery Devices $988 Mn $1.9 Bn 7% –
Insulin Patch Pumps $55 Mn $180 Mn 12.5% –
Rehabilitation Equipments $1.2 Bn $2.4 Bn 6.6% –
OTC & Nutraceuticals 48 markets
OTC & Nutraceuticals markets in Japan
Market20232033 (projected)CAGR Active trials
Adaptogens $504 Mn $1.2 Bn 9% –
Amino Acid – – – –
Anthelmintic Drug – – – –
Antioxidants – – – –
Antipyretics OTC – – – –
BCAA Supplement $87 Mn $174 Mn 7.2% –
Beauty Supplements $255 Mn $643 Mn 9.7% –
Biotin Supplement $25 Mn $43 Mn 5.5% –
Bone & Joint Health Supplements $746 Mn $1.5 Bn 6.9% –
Calcium Supplements $155 Mn $292 Mn 6.5% –
Cannabidiol (CBD) Supplements $329 Mn $1.6 Bn 17.3% –
Cardiovascular Health Supplements $423 Mn $771 Mn 6.2% –
Clinical Nutrition $1.8 Bn $3.7 Bn 7.6% –
Coenzyme Q10 $31 Mn $77 Mn 9.5% –
Collagen Supplements $137 Mn $259 Mn 6.6% –
Creatine $37 Mn $72 Mn 6.8% –
Dietary Supplements $19.1 Bn $36.6 Bn 6.7% –
Eye Health Supplements $193 Mn $369 Mn 6.7% –
Functional Food $17.7 Bn $35.5 Bn 7.2% –
Hair Growth Supplements $112 Mn $237 Mn 7.8% –
Herbal Supplements $5.1 Bn $11.1 Bn 8.1% –
Immune Health Supplement – – – –
Iron Supplement $124 Mn $245 Mn 7% –
Men's Health Supplements $1.1 Bn $2.3 Bn 7.3% –
Mood and Stress Supplements $653 Mn $1.5 Bn 8.6% –
Nutritional Supplements $23.9 Bn $48.4 Bn 7.3% –
Omega 3 Fatty Acid $255 Mn $545 Mn 7.9% –
Oncology Nutrition $131 Mn $277 Mn 7.8% –
Osteoporosis Supplements $193 Mn $379 Mn 7% –
Over The Counter (OTC) Analgesics $1.4 Bn $2 Bn 3.9% –
Over The Counter (OTC) Antifungal $155 Mn $237 Mn 4.3% –
Over The Counter (OTC) Consumer $9.4 Bn $16.3 Bn 5.7% –
Over The Counter (OTC) Drugs $11.1 Bn $18.4 Bn 5.2% –
Over The Counter (OTC) Gastrointestinal Drugs $348 Mn $535 Mn 4.4% –
Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs $901 Mn $1.4 Bn 4.6% –
Over The Counter (OTC) Ophthalmic Drugs $224 Mn $365 Mn 5% –
Over The Counter (OTC) Pharmaceuticals $11.1 Bn $18.4 Bn 5.2% –
Over The Counter (OTC) Sleep Aid Products $329 Mn $512 Mn 4.5% –
Over The Counter (OTC) Vitamins and Minerals $2 Bn $3.6 Bn 6% –
Plant-Based Supplements $765 Mn $1.7 Bn 8.5% –
Prebiotics $504 Mn $1.6 Bn 12.3% –
Probiotic Supplements for Gut Health $379 Mn $796 Mn 7.7% –
Protein Supplement $1.2 Bn $2.7 Bn 7.9% –
Sports Nutrition $3.2 Bn $7.2 Bn 8.4% –
Vitamin B12(Cobalamin) $19 Mn $33 Mn 6% –
Vitamin D Supplements – – – –
Weight Management Supplement – – – –
Women's Health Supplements $1.2 Bn $2.5 Bn 7.3% –
Pharmaceuticals 38 markets
Pharmaceuticals markets in Japan
Market20232033 (projected)CAGR Active trials
Abuse Deterrent Opioids – – – –
Alexipharmic Drugs – – – –
Alopecia Drugs (Hair Loss) – – – –
Alzheimer Drugs $311 Mn $630 Mn 7.3% –
Aminoglycosides – – – –
Anemia Drugs – – – –
Anti-Aging $5.5 Bn $12.5 Bn 8.6% –
Anti-Depressants Drugs $1.1 Bn $1.5 Bn 3.2% –
Anti-Nerve Growth Factor – – – –
Anti-Venom – – – –
Anticoagulants – – – –
Antithrombotic Drugs – – – –
Artificial Skin $155 Mn $286 Mn 6.3% –
Asthma & COPD Drugs $3.1 Bn $4.8 Bn 4.5% –
Atherosclerosis Drugs – – – –
Atopic Dermatitis Drugs $698 Mn $2.3 Bn 12.7% –
Autologous Matrix-induced Chondrogenesis – – – –
Axial Spondyloarthritis (axSpA) – – – –
Biological Safety Testing – – – –
Biosimilar Monoclonal Antibodies – – – –
Biosimilars $2.3 Bn $22.1 Bn 25.4% –
Blood Plasma – – – –
Bone Marrow Aspirate Concentrates – – – –
Burn Care – – – –
Burn Ointment – – – –
Cancer Supportive Care Drugs $1.5 Bn $2.6 Bn 5.2% –
Cannabidiol (CBD) $1.4 Bn $6.8 Bn 17.3% –
Cannabis $2.1 Bn $7.8 Bn 14% –
Cell Based Immunotherapy $1 Bn $8.5 Bn 23.5% –
Contraceptives Drugs $1.6 Bn $3.2 Bn 7.3% –
Cord Blood Banking Service $118 Mn $232 Mn 7% –
Diabetes Management $4.8 Bn $10.1 Bn 7.6% –
Diabetic Retinopathy Drugs $671 Mn $1.3 Bn 6.5% –
Epilepsy Drugs $597 Mn $883 Mn 4% –
Gastroesophageal Reflux Disease (GERD) Drugs $323 Mn $418 Mn 2.6% –
Gastrointestinal Drugs $3.4 Bn $5.5 Bn 5.1% –
HIV Drugs $1.9 Bn $3.4 Bn 6.3% –
Oncology/Cancer Drugs $11 Bn $25.8 Bn 8.9% –

"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.

Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.

Consult us Planning for Japan? We can size your market, compare regions and name the key companies. Talk to us Browse the reports All 178 Japan reports, with a free sample of each. See reports See the public data Compare Japan with the world on 94 free health measures. Open the Public Health Dashboard

All 178 Japan reports Other countries